Remus Pharma submits SEBI Regulation 74(5) certificate for Q3 FY2026 from MUFG Intime India, signaling routine regulatory compliance and updated depository records.
AI Assistant
Remus Pharmaceuticals Ltd
2026
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.